Genetic Susceptibility and Biomarkers of Platinum-Related Toxicities

Study ID Alternative Stable ID Type
phs001621 Longitudinal

Study Description

The Platinum Study is an R01-funded, multicenter study of testicular cancer survivors that characterizes both long-term cisplatin-induced peripheral neuropathy (CisIPN) and cisplatin-associated ototoxicity, i.e., permanent, bilateral hearing loss. We collected data abstracted from medical records (e.g., cumulative cisplatin dose), conducted audiometric examinations, and administered self-report questionnaires, which included CisIPN symptoms.

Archive Link Archive Accession
dbGaP phs001621

Who archives the data?

There are no publications available